|
Stem cell therapy in Bangkok
Thailand and stem cell treatment
Are you looking for the best place
in Bangkok to consider having some stem cell treatments? We have
done all the research for you and now we are very happy to provide
you with all your Bangkok Thailand stem cell information, needs,pricing
and more.
Although stem cells sounds futuristic, innovative science fiction
cutting edge medicine, this therapy has actually been around for
quite some time. In the past, these cells were very difficult and
overly expensive to obtain. With today's new techniques and equipment,
stem cells can easily be obtained and concentrated by a simple office
procedure.
History
For over 60 years, Stem Cells have been used to treat patients
with conditions such as Leukemia and Lymph Node Cancer. This is
know as a bone marrow transplant, using Mesenchymal Stem Cells (
MSC's) . Today, these MSC's have been found and are now collected
from the patients own fat. These Fat derived stem cells are used
in the treatment of a wide range of conditions with positive and
encouraging results.
Every living person has stem cells in their body. Stem cells function
is to do the repairs of the body. The most common is known as hematopoietic
stem cells (HSC-CD 34+). The type of adult stem cell that is most
often seen in research as being associated with tissue repair is
a mesenchymal stem cell (MSC). These cells travel to the injured
areas ofthe body via the blood stream. If the injured area has a
poor blood supply, this is called an area of hypoxia or low oxygen
content. Areas of hypoxia include the joints, meniscus tissue, rotator
cuff and other tendon injuries. These are areas that typically do
not heal on their own. The body is not able to get enough of the
repair cells to these injured areas which do not get enough blood.
Since there is a poor blood supply in this area, the body has trouble
sensing an injury is present.
In Bangkok there are now a lot of highly specialized and qualified
medical centers and hospitals that routinely perform stell cell
treatments. Stem cell treatment is one of the more promising medical
advances in the history of medicine. On this site we will offer
various information of the types of conditions and ailments that
stell cell therapy can benefit the patient. These treatments include
heart disease, spinal
injury, Parkinson's
Disease and many more diseases. See a list on the right side
of this page for the various diseases and ailments that stem cell
therapy can treat.
In Bangkok, some of the country's best and world class hospitals
offer stem cell therapy and treatment. These hospitals include Bumrumgrad
Hospital, Bangkok Hospital,
Bangkok Heart Hospital,
Bangkok Dental Hospital,
Chaophya Hospital,
Samitivej Hospital,
and Vejthani Hospital.
Latest News
Embryonic stem cells appear to restore
some vision to legally blind patient
For the first time, an experimental treatment made
from human embryonic stem cells has shown evidence of helping someone,
partially restoring sight to two people suffering from slowly progressing
forms of blindness.
Although the purpose of the experiment was to test the safety of
stem cells injected into the eye, both patients “had measurable
improvement in their vision that persisted through the duration
of the study,” said Robert Lanza, chief scientific officer
at Advanced Cell Technology, the Massachusetts biotech company that
sponsored the closely watched experiment.
The operations in July on two Southern California women yielded
practical results. One of them no longer needs a large magnifying
glass to read and can reportedly thread a needle. The other has
begun to go shopping on her own.
Reported online in the Lancet on Monday, the project used the cells
under highly favorable conditions not likely to exist with many
diseases.
The cells were transplanted into the eye, an organ in which the
chance of immune rejection is low. The complex, 10-layer architecture
of the retina was intact, so the cells were not asked to perform
a heroic act of reconstruction. The researchers were able to monitor
progress — and watch for complications — in real time
by looking into the eyes.
Lanza cautioned that the findings are preliminary, the improvements
could disappear and complications could emerge. Nevertheless, he
thinks the two cases will provide useful lessons for the field.
“Hopefully, this is just the beginning of many exciting new
stem cell therapies that will move from bench to bedside in the
next few years,” he said.
This field of research has stirred high hopes and bitter debate
in recent years.
Embryonic stem cells are able to develop into virtually any type
of tissue in the body, but to obtain them, embryos are manipulated
and sometimes destroyed. Many researchers hope the cells —
or other “pluripotent” cells derived from less controversial
sources — will offer cures for heart disease, cancer, Alzheimer’s
dementia, spinal cord injury and other ailments.
Until now, the strategy had shown promise only in laboratory studies
and animal tests. After many delays, the Food and Drug Administration
last year approved two experiments in people. The blindness trial
is the first to publish evidence that the approach might be working.
Adult Stem Cells Could Improve Angioplasy Outcome
A Creighton University School of Medicine researcher has received
a $3.3 million, five-year grant from the National Institutes of
Health to study what role adult stem cells might play in repairing
damaged coronary arteries, a complication that often occurs in patients
after they undergo angioplasty and stenting.
“Restenosis, a re-narrowing of coronary arteries in the heart,
after balloon angioplasty and the placement of stents, is a serious
problem. Drug-eluting stents can help reduce the occurrence of restenosis.
However, there is a serious tradeoff.
Drug-eluting stents can lead to thrombosis (platelet deposits in
the endothelial lining around the blood vessels that destroy the
lining), which then requires longer periods of anti-platelet therapy.
This therapy, in turn, can produce serious side effects, including
nosebleed, upset stomach, nausea and diarrhea,” said Devendra
Agrawal, Ph.D., principal investigator and a professor of biomedical
sciences, internal medicine and medical microbiology and immunology.
For the study, Agrawal and his co-investigators, Creighton cardiologist
Michael Del Core and pathologist William Hunter will deliver adult
stem cells (autologous mesenchymal stem cells), together with a
novel gene, at the site of an interventional procedure in the coronary
arteries of a pig model.
The goal is to determine whether the administration of adult stem
cells, along with the gene therapy, is superior to using drug-eluting
stents following angioplasty, said Agrawal, holder of The Peekie
Nash Carpenter Endowed Chair in Medicine. If successful, he added,
the treatment could even eliminate the need for stents.
Recent research has shown that angioplasty and stenting –
commonly used to open narrowed coronary arteries – are not
as effective as once thought.
In fact, a study involving more than 15,000 patients and published
Nov. 28 online by the Archives of Internal Medicine, shows that
it can even do more harm than good in some patients. According to
the study, nearly one in 10 patients undergoing coronary angioplasty
was readmitted to a hospital within 30 days, and these patients
were at higher risk of death within one year.
With angioplasty, a catheter-guided balloon is inserted to open
a narrowed coronary artery. A wire mesh stent is typically implanted
during the procedure to keep the artery open.
Eleven to18 percent of all patients experience restenosis or a
re-narrowing of the artery within three-four years, said Agrawal.
This is the second grant Agrawal has received in recent months
to explore alternatives to stenting. The first grant totaled $2.58
million over four years.
Stem cell therapy
in Bangkok Thailand and stem cell treatment
|
